{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:29:17Z","timestamp":1786663757627,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the diagnostic performance of [\u00b9\u00b9C]methionine (MET) PET\/CT for preoperative localisation in primary hyperparathyroidism (PHPT) with negative or inconclusive first-line imaging, and to compare it with [\u00b9\u00b9C]choline (CHO) PET\/CT in a head-to-head analysis, focusing on determinants of adenoma detectability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifty-one patients with biochemically confirmed PHPT underwent MET PET\/CT following inconclusive conventional imaging. In a subgroup of 25 patients, CHO PET\/CT was also performed. Imaging findings were correlated with surgical and histopathological results. Detection rates and positive predictive values (PPV) were calculated, and semiquantitative parameters, including standardized uptake value (SUV) and lesion-to-background ratio (LBR), were analysed. Associations between PET findings, biochemical markers, and adenoma weight were explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MET PET\/CT achieved a patient-based detection rate of 76.5% with a PPV of 88.2%. In the head-to-head subgroup, CHO detected more lesions than MET (27 vs. 14;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0025) and identified all histologically confirmed adenomas, with comparable PPVs (90.0% vs. 77.8%). CHO demonstrated significantly higher SUV and LBR values. Adenoma weight was significantly associated with PET findings: MET-positive adenomas were significantly heavier than MET-negative adenomas, whereas CHO maintained high lesion detection even in adenomas weighing 0.5\u00a0g or less. Additionally, a trend towards higher uptake with increasing PTH and calcium levels was observed for CHO SUVmax.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adenoma weight appears to be a major determinant of PET detectability in PHPT. The ability of CHO PET\/CT to detect adenomas weighing 0.5\u00a0g or less, which may remain occult on MET, provides a plausible explanation for its superior lesion detection, while both tracers maintain a high positive predictive value. These findings further support the use of choline-based PET imaging in patients with inconclusive first-line studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00259-026-08116-6","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:17:53Z","timestamp":1786663073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative performance of 11C-methionine and 11C-choline PET\/CT in primary hyperparathyroidism: Impact of adenoma weight on PET detectability"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-5734","authenticated-orcid":false,"given":"Laura","family":"Garc\u00eda Belaustegui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-9310","authenticated-orcid":false,"given":"Magdalena","family":"de la Higuera L\u00f3pez-Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"de Abajo-Larriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Basanta Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Fernando","family":"Bastidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Morales Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Grissanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Arbizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"4","key":"8116_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2265.2008.03520.x","volume":"71","author":"N Yu","year":"2009","unstructured":"Yu N, Donnan PT, Murphy MJ, Leese GP. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin Endocrinol (Oxf). 2009;71(4):485\u201393. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03520.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"8116_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.reumae.2011.06.002","volume":"8","author":"I Mart\u00ednez-Cordellat","year":"2012","unstructured":"Mart\u00ednez-Cordellat I. Hyperparathyroidism: Primary or secondary disease? Reumatol Clin (Engl Ed). 2012;8(5):287\u201391. https:\/\/doi.org\/10.1016\/j.reumae.2011.06.002.","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"9684","key":"8116_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145\u201358. https:\/\/doi.org\/10.1016\/S0140-6736(09)60507-9.","journal-title":"Lancet"},{"issue":"3","key":"8116_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s002689900230","volume":"21","author":"ON Gofrit","year":"1997","unstructured":"Gofrit ON, Lebensart PD, Pikarsky A, Lackstein D, Gross DJ, Shiloni E. High-resolution ultrasonography: highly sensitive, specific technique for preoperative localization of parathyroid adenoma in the absence of multinodular thyroid disease. World J Surg. 1997;21(3):287\u201391. https:\/\/doi.org\/10.1007\/s002689900230.","journal-title":"World J Surg"},{"issue":"2","key":"8116_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","volume":"19","author":"K Cheung","year":"2012","unstructured":"Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012;19(2):577\u201383. https:\/\/doi.org\/10.1245\/s10434-011-1870-5.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"8116_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/wjnm.WJNM_29_18","volume":"18","author":"M Vaiman","year":"2019","unstructured":"Vaiman M, Cohenpur M, Halevy A, Volkov O, Gold R, Peer M, et al. Low radiation dose of technetium-99m-sestamibi and single-photon emission computed tomography\/computed tomography to diagnose parathyroid lesions. World J Nucl Med. 2019;18(1):52\u20137. https:\/\/doi.org\/10.4103\/wjnm.WJNM_29_18.","journal-title":"World J Nucl Med"},{"issue":"S1","key":"8116_CR7","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/hed.24027","volume":"38","author":"G Treglia","year":"2016","unstructured":"Treglia G, Sadeghi R, Schalin-J\u00e4ntti C, Caldarella C, Ceriani L, Giovanella L, et al. Detection rate of 99mTc-MIBI single photon emission computed tomography (SPECT)\/CT in preoperative planning for patients with primary hyperparathyroidism: a meta-analysis. Head Neck. 2016;38(S1):1391\u2013400. https:\/\/doi.org\/10.1002\/hed.24027.","journal-title":"Head Neck"},{"issue":"3","key":"8116_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","volume":"132","author":"JM Ruda","year":"2005","unstructured":"Ruda JM, Hollenbeak CS, Stack BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132(3):359\u201372. https:\/\/doi.org\/10.1016\/j.otohns.2004.10.005.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"8116_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2967\/jnumed.121.263123","volume":"63","author":"C Mathey","year":"2022","unstructured":"Mathey C, Keyzer C, Blocklet D, Van Simaeys G, Trotta N, Lacroix S, et al. 18F-fluorocholine PET\/CT is more sensitive than 11\u00a0C-methionine PET\/CT for the localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism. J Nucl Med. 2022;63(5):785\u201391. https:\/\/doi.org\/10.2967\/jnumed.121.263123.","journal-title":"J Nucl Med"},{"issue":"7","key":"8116_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00423-016-1425-0","volume":"401","author":"WP Kluijfhout","year":"2016","unstructured":"Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Gosnell JE, Shen WT, et al. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbecks Arch Surg. 2016;401(7):925\u201335. https:\/\/doi.org\/10.1007\/s00423-016-1425-0.","journal-title":"Langenbecks Arch Surg"},{"issue":"5","key":"8116_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00259-023-06573-x","volume":"51","author":"G Treglia","year":"2024","unstructured":"Treglia G, Rizzo A, Piccardo A. Expanding the clinical indications of 18F-fluorocholine PET\/CT in primary hyperparathyroidism: the evidence cannot be evaded. Eur J Nucl Med Mol Imaging. 2024;51(5):1345\u20138. https:\/\/doi.org\/10.1007\/s00259-023-06573-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"8116_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s00259-023-06488-7","volume":"51","author":"ME Noltes","year":"2024","unstructured":"Noltes ME, Kruijff S, Appelman APA, Jansen L, Zandee WT, Links TP, et al. Head-to-head comparison of 11\u00a0C-methionine PET, 11\u00a0C-choline PET, and 4-dimensional CT as second-line scans for detection of parathyroid adenomas in primary hyperparathyroidism. Eur J Nucl Med Mol Imaging. 2024;51(4):1050\u20139. https:\/\/doi.org\/10.1007\/s00259-023-06488-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"8116_CR13","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.21037\/qims-22-584","volume":"13","author":"K Pogosian","year":"2023","unstructured":"Pogosian K, Karonova T, Ryzhkova D, Yanevskaya L, Tsoy U, Yudina O, et al. 11C-methionine PET\/CT and conventional imaging techniques in the diagnosis of primary hyperparathyroidism. Quant Imaging Med Surg. 2023;13(4):2352\u201363. https:\/\/doi.org\/10.21037\/qims-22-584.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"8116_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13550-019-0486-5","volume":"9","author":"ME Noltes","year":"2019","unstructured":"Noltes ME, Kruijff S, Noordzij W, Telenga ED, V\u00e1llez Garc\u00eda D, Trofimiuk-M\u00fcldner M, et al. Optimization of parathyroid 11\u00a0C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism. EJNMMI Res. 2019;9(1):20. https:\/\/doi.org\/10.1186\/s13550-019-0486-5.","journal-title":"EJNMMI Res"},{"issue":"3","key":"8116_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/archsurg.2011.5","volume":"146","author":"ML Richards","year":"2011","unstructured":"Richards ML, Thompson GB, Farley DR, Grant CS. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg. 2011;146(3):280\u20135. https:\/\/doi.org\/10.1001\/archsurg.2011.5.","journal-title":"Arch Surg"},{"issue":"11","key":"8116_CR16","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GEH, Marcocci C, Minisola S, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res. 2022;37(11):2293\u2013314. https:\/\/doi.org\/10.1002\/jbmr.4677.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"8116_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/EJE-21-0038","volume":"185","author":"F Bioletto","year":"2021","unstructured":"Bioletto F, Barale M, Parasiliti-Caprino M, Prencipe N, Berton AM, Procopio M, et al. Comparison of the diagnostic accuracy of 18F-fluorocholine PET and 11C-methionine PET for parathyroid localization in primary hyperparathyroidism: a systematic review and meta-analysis. Eur J Endocrinol. 2021;185(1):109\u201320. https:\/\/doi.org\/10.1530\/EJE-21-0038.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"8116_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.remnie.2025.500129","volume":"44","author":"E Campa\u00f1a D\u00edaz","year":"2025","unstructured":"Campa\u00f1a D\u00edaz E, G\u00f3mez-Caminero L\u00f3pez F, \u00c1lvarez P\u00e9rez JM, Montes Fuentes C, Rama Alonso S, Badell Mart\u00ednez JA, et al. 18F-choline PET\/CT in the study of primary hyperparathyroidism: evaluation of the technique, visual and semi-quantitative analysis and correlation with other imaging techniques. Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition). 2025;44(5):500129. https:\/\/doi.org\/10.1016\/j.remnie.2025.500129.","journal-title":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"},{"key":"8116_CR19","doi-asserted-by":"publisher","unstructured":"Jeong HB, Kim YI, Yoon S, Lee DY, Kim BJ, Lee SH et al. Diagnostic ability and correlation of digital 11\u00a0C-methionine PET\/CT in primary hyperparathyroidism with inconclusive standard imaging. Nucl Med Mol Imaging (2010). 2025;59(1):72\u201378. https:\/\/doi.org\/10.1007\/s13139-024-00869-0","DOI":"10.1007\/s13139-024-00869-0"},{"issue":"4","key":"8116_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.remnie.2025.500091","volume":"44","author":"S Casanueva-Eliceiry","year":"2025","unstructured":"Casanueva-Eliceiry S, Manyalich-Blasi M, Farr\u00e9-Melero A, Ni\u00f1erola-Baiz\u00e1n A, Saavedra D, Mora-Porta M, et al. Redefining preoperative imaging-based localization of adenomas in primary hyperparathyroidism patients candidates for minimally invasive surgery. Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition). 2025;44(4):500091. https:\/\/doi.org\/10.1016\/j.remnie.2025.500091.","journal-title":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"},{"issue":"4","key":"8116_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s11307-023-01808-7","volume":"25","author":"S Vestergaard","year":"2023","unstructured":"Vestergaard S, Gerke O, Bay M, Madsen AR, Stilgren L, Ejersted C, et al. Head-to-head comparison of 99mTc-sestamibi SPECT\/CT and 11\u00a0C-methionine PET\/CT in parathyroid scanning before operation for primary hyperparathyroidism. Mol Imaging Biol. 2023;25(4):720\u20136. https:\/\/doi.org\/10.1007\/s11307-023-01808-7.","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"8116_CR22","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1049","volume":"186","author":"J Bollerslev","year":"2022","unstructured":"Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). Eur J Endocrinol. 2022;186(2):R33\u201363. https:\/\/doi.org\/10.1530\/EJE-21-1049.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"8116_CR23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00268-019-05345-8","volume":"44","author":"R Krawitz","year":"2020","unstructured":"Krawitz R, Glover A, Koneru S, Jiang J, Di Marco A, Gill AJ, et al. The significance of histologically large normal parathyroid glands in primary hyperparathyroidism. World J Surg. 2020;44(4):1149\u201355. https:\/\/doi.org\/10.1007\/s00268-019-05345-8.","journal-title":"World J Surg"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08116-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08116-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08116-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:17:55Z","timestamp":1786663075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-08116-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":23,"alternative-id":["8116"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08116-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}